[go: up one dir, main page]

CO5180536A1 - Inhibidores de proteasas catepsina - Google Patents

Inhibidores de proteasas catepsina

Info

Publication number
CO5180536A1
CO5180536A1 CO00023372A CO00023372A CO5180536A1 CO 5180536 A1 CO5180536 A1 CO 5180536A1 CO 00023372 A CO00023372 A CO 00023372A CO 00023372 A CO00023372 A CO 00023372A CO 5180536 A1 CO5180536 A1 CO 5180536A1
Authority
CO
Colombia
Prior art keywords
alkyl
group
het
alkenyl
catepsin
Prior art date
Application number
CO00023372A
Other languages
English (en)
Inventor
Dennis Shinji Yamashita
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5180536A1 publication Critical patent/CO5180536A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/12—Eight-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de Fórmula I: <EMI FILE="00023372_1" ID="1" IMF=JPEG >en la cual: R1 se selecciona del grupo constituido por: R", R"C(O), R"C(S), R"SO2, R"OC(O), R"R´NC(O), y R"OC(O)NR´CH(R6)C(O);R2 se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, Ar-alquilo C0-6, y Het-alquilo C0-6; R3 se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, alquinilo C2-6, cicloalquil C3-6-alquiloC0-6, Ar-alquilo C0-6, y Het-alquilo C0-6;R4 se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, Ar-alquilo C0-6, y Het-alquilo C0-6;R5 se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, Ar-alquilo C0-6, y Het-alquilo C0-6; R6 se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, cicloalquil C3-6-alquilo C0-6, Ar-alquilo C0-6 y Het-alquilo C0-6;R7 se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, cicloalquil C3-6, -alquilo C0-6, Ar-alquilo C0-6 y Het-alquilo C0-6; R8 se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, cicloalquil C3-6 -alquilo C0-6, Ar-alquilo C0-6, y Het-alquilo C0-6;R´ se selecciona del grupo constituido por: H, alquilo C1-6, alquenilo C2-6, Ar-alquilo C0-6, y Het-alquilo C0-6; R" se selecciona del grupo constituido por: alquilo C1-6, Ar-alquilo C0-6, Het-alquilo C0-6, Ar-alquenilo C2-6 y Hetalquenilo C2-6;X se selecciona del grupo constituido por: 0 y S; e Y se selecciona del grupo constituido por: 0 y S; y sus sales, hidratos y solvatos farmacéuticamente aceptables.
CO00023372A 1999-03-31 2000-03-31 Inhibidores de proteasas catepsina CO5180536A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12725099P 1999-03-31 1999-03-31

Publications (1)

Publication Number Publication Date
CO5180536A1 true CO5180536A1 (es) 2002-07-30

Family

ID=22429122

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00023372A CO5180536A1 (es) 1999-03-31 2000-03-31 Inhibidores de proteasas catepsina

Country Status (8)

Country Link
EP (1) EP1173429A4 (es)
JP (1) JP2002540199A (es)
AU (1) AU4066900A (es)
CO (1) CO5180536A1 (es)
HK (1) HK1044758A1 (es)
PE (1) PE20001607A1 (es)
UY (1) UY26088A1 (es)
WO (1) WO2000058296A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
JP2003513924A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
WO2001034600A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
EP1232155A4 (en) 1999-11-10 2002-11-20 Smithkline Beecham Corp PROTEASE INHIBITORS
CZ20023168A3 (cs) 2000-03-21 2003-02-12 Smithkline Beecham Corporation Inhibitory proteázy
JP2005515254A (ja) 2002-01-17 2005-05-26 スミスクライン ビーチャム コーポレーション カテプシンｋ阻害剤として有用なシクロアルキルケトアミド誘導体
JP2004196696A (ja) * 2002-12-18 2004-07-15 Kyowa Hakko Kogyo Co Ltd 関節炎の予防剤または治療剤
CN113651795B (zh) * 2021-09-14 2022-09-02 江西开源香料有限公司 一种西瓜酮的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374623A (en) * 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use

Also Published As

Publication number Publication date
JP2002540199A (ja) 2002-11-26
AU4066900A (en) 2000-10-16
PE20001607A1 (es) 2001-03-07
WO2000058296A1 (en) 2000-10-05
HK1044758A1 (zh) 2002-11-01
EP1173429A4 (en) 2002-06-19
EP1173429A1 (en) 2002-01-23
UY26088A1 (es) 2000-10-31

Similar Documents

Publication Publication Date Title
NO20013379L (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
DE60135764D1 (de) Stickstoffhaltige, fünfgliedrige ringverbindungen
AR240929A2 (es) &#34;n-piridinsulfonil-n&#39;-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas&#34;
CO5200785A1 (es) Uso terapeutico de quinazolina
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
DE69923692D1 (de) Wachstumshormon-freisetzende oxindolderivate
FI883669A0 (fi) 1-/(4-piperidinyl) metyl/ -1,2,3,4-tetrahydro-9h-pyrido/3.4-b/ indolderivat, deras framstaellning och terapeutiska anvaendning.
CO5180629A1 (es) Pirimidina-2,4,6-ttrionas inhibidores de metaloproteinasas
CO5261565A1 (es) Inhibidores de n-(5-(((5-alquil-2-oxazolil)metil)tio)-2-tiazolil)-carboxamida de cinasas dependientes de ciclina
BG103258A (en) Azinyloxy- and phenoxydiaryl derivatives of carboxylic acids, their preparation and application as mixed eta/etb endothelin-receptor antagonists
CO5180536A1 (es) Inhibidores de proteasas catepsina
TW200505446A (en) Inhibitor of cox
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
CO5180541A1 (es) Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros
EA200400666A3 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
KR970706280A (ko) 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists)
CO5080787A1 (es) Isoquinolinas
SV2001000050A (es) Compuestos farmaceuticos caso n.g.1336
DK0435235T3 (da) Nye isoquinolinderivater og salte deraf
CO5150177A1 (es) Derivados de hidrazina
TW200510300A (en) Amino alcohol compounds

Legal Events

Date Code Title Description
FA Application withdrawn